Cargando…
T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
PURPOSE OF THE RESEARCH: We proposed T-cell lymphocytopenia as a strategic predictor of serious coronavirus and influenza infections. Our preeminent goal was to determine whether a degree of T-cell lymphopenia would identify a distinct threshold cell count to differentiate between severe and non-sev...
Autores principales: | Putter, Jeffrey S., Seghatchian, Jerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933323/ https://www.ncbi.nlm.nih.gov/pubmed/36989654 http://dx.doi.org/10.1016/j.cyto.2023.156163 |
Ejemplares similares
-
An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research
por: Putter, Jeffrey S., et al.
Publicado: (2020) -
Spotlight on SARS CoV-2 infection inducing autoimmunity, through the formation of autoantibody to self hemostatic components or to host cells, often leading to severe thrombotic or bleeding events
por: Seghatchian, Jerard
Publicado: (2023) -
SARS-CoV-2 and cancer: the intriguing and informative cross-talk
por: Goubran, Hadi, et al.
Publicado: (2022) -
New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, Jerard
Publicado: (2021) -
Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity
por: Seghatchian, Jerard
Publicado: (2022)